Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vertex Pharmaceuticals Incorporated
With
Cystic Fibrosis Foundation
Age
6–11
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Subject must be 11 years of age or younger at the time of treatment initiation with ivacaftor (as part of clinical trial) or commercially-available ivacaftor.
2. Subject must reside in the US and be receiving or planning to receive commercially-available ivacaftor.
You may not be if
1. Subject is enrolled in an ivacaftor clinical study in which ivacaftor exposure is mandated by the protocol.